Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00489944
What this trial is testing

Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma

Who this might be right for
Intraocular Melanoma
San Diego Pacific Oncology & Hematology Associates 50
Large-scale testing (Phase 3)Looking for participantsNCT06624644
What this trial is testing

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Who this might be right for
Melanoma (Skin Cancer)Melanoma Stage IIIB-IVCutaneous Melanoma+1 more
Linnaeus Therapeutics, Inc. 135
Testing effectiveness (Phase 2)Study completedNCT01196416
What this trial is testing

Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma

Who this might be right for
Recurrent MelanomaStage IV Skin Melanoma
National Cancer Institute (NCI) 14
Early research (Phase 1)Active Not RecruitingNCT03025256
What this trial is testing

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

Who this might be right for
Acral Lentiginous MelanomaCentral Nervous System MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8+7 more
M.D. Anderson Cancer Center 75
Testing effectiveness (Phase 2)UnknownNCT00010309
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Genzyme, a Sanofi Company
Early research (Phase 1)Study completedNCT00438009
What this trial is testing

A Safety Study of Two Intratumoural Doses of Coxsackievirus Type A21 in Melanoma Patients (PSX-X03)

Who this might be right for
Stage IV Melanoma
Viralytics 9
Testing effectiveness (Phase 2)Study completedNCT00289016
What this trial is testing

Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant Melanoma

Who this might be right for
Melanoma
BioVex Limited 50
Large-scale testing (Phase 3)UnknownNCT00477906
What this trial is testing

M-Vax + Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma

Who this might be right for
Melanoma
AVAX Technologies 387
Not applicableStudy completedNCT01010984
What this trial is testing

LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma

Who this might be right for
Stage IV Melanoma
Robert C. Martin 20
Testing effectiveness (Phase 2)Ended earlyNCT03241927
What this trial is testing

Pembrolizumab Effects on NK Cell Exhaustion in Melanoma (Merck NK-IIT)

Who this might be right for
Melanoma
Nina Bhardwaj 1
Early research (Phase 1)Study completedNCT00217542
What this trial is testing

Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaRecurrent Renal Cell CancerStage III Melanoma+2 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Ended earlyNCT02203604
What this trial is testing

High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+2 more
CINJRegulatory 9
Testing effectiveness (Phase 2)Study completedNCT00006233
What this trial is testing

Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07215182
What this trial is testing

[68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer

Who this might be right for
Malignant Melanoma Stage IV
Barbara Malene Fischer 20
Testing effectiveness (Phase 2)Study completedNCT00058279
What this trial is testing

Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06651151
What this trial is testing

NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma

Who this might be right for
Melanoma Stage IIIB-IV
Oslo University Hospital 27
Testing effectiveness (Phase 2)Study completedNCT00044356
What this trial is testing

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Who this might be right for
MelanomaMetastatic MelanomaMalignant Melanoma+1 more
Vical 133
Testing effectiveness (Phase 2)Study completedNCT00019994
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01227551
What this trial is testing

Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )

Who this might be right for
Malignant Melanoma
Viralytics 57
Testing effectiveness (Phase 2)UnknownNCT01217398
What this trial is testing

Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye

Who this might be right for
Intraocular Melanoma
Institut Curie 35
Next Page